Canada markets close in 3 hours 7 minutes

Codexis, Inc. (CDXS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.4950+0.0950 (+2.79%)
As of 12:48PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close3.4000
Bid3.4700 x 200
Ask3.5300 x 100
Day's Range3.3800 - 3.5400
52 Week Range1.4500 - 4.9100
Avg. Volume597,293
Market Cap246.599M
Beta (5Y Monthly)2.05
PE Ratio (TTM)N/A
EPS (TTM)-0.9400
Earnings DateAug 01, 2024 - Aug 05, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.57
  • GlobeNewswire

    Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

    REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will participate in a panel discussion titled, “Sustainable API Manufacturing” at the TD Cowen 2nd Annual Sustainability Week, being held virtually May 21-23, 2024. During the presentation, Management will highlight the potential benefits of an enzymatic route of synthesis in the manufacture of small molecule and siRNA therapeutics. The panel will

  • GlobeNewswire

    Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

    REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has successfully synthesized an oligonucleotide via an enzymatic route to support RNA-based therapeutics manufacturing. Data highlighting this historic manufacturing milestone are being presented today in a Spotlight Presentation at the TIDES USA annual meeting taking place in Boston, MA, and virtually May 14 – 17, 2024. “The data presented today by Codexi

  • Simply Wall St.

    Codexis First Quarter 2024 Earnings: Beats Expectations

    Codexis ( NASDAQ:CDXS ) First Quarter 2024 Results Key Financial Results Revenue: US$17.1m (up 32% from 1Q 2023). Net...